2016 Midkine Symposium Program




  9:00-10:15am            SESSION 5: MK & PTN in Angiogenesis & Bone

 Session Moderator:     Associate Professor Graham Robertson

 9:00am-9:45am

 

Professor Evangelia Papadimitriou, University of Patras, Patras, Greece

  

PLENARY 2: Pleiotrophin and its receptor RPTP beta/zeta as angiogenesis regulators  


More Details 


 9:45am-10:15am

 

Dr Astrid LiedertUniversity Medical Centre Ulm, Germany

Anti-midkine antibody treatment accelerates Fracture healing in mice 


More Details 


 10:15am-11:00am       Morning tea and poster viewing

 11:00am-12:15pm       SESSION 6: Midkine in cardiovascular disease                                   

 Session Moderator:     Maria Halasz

 11:00am-11:30am

 

Professor Peter FerdinandySemmelweis Uni and PharmaHungary, Budapest Hungary

Midkine protein therapeutics in preclincial models of cardiac muscle injury


More Details


 11:30am -12:00pm

 

Dr Ulrich Grabmaier, Ludwig-Maximilians-University, Munich, Germany

Targeting the N-terminal Domain of Midkine attenuates leukocyte infiltration and cardiac fibrosis & dysfunction in experimental autoimmune Myocarditis



More Details 

 12:00pm-12:15pm

 

Ms Sharron HallCellmid Ltd & Hunter MRI, Newcastle, Australia

Midkine levels in acute and prolonged Exercise by Elite Athletes


More Details 


12:15pm-1:30pm         Lunch and networking

 1:30pm-2:50pm         SESSION 7:  Midkine and cancer

 Session Moderator:     Joseph Haklani

 1:30pm-2:00pm

 

Professor Guillermo VelascoComplutense Universidad, Madrid, Spain

Role of the Midkine/ALK axis in gliomas


More Details 


 2:00pm-2:30pm

 

Dr Margarete KargUniversity Hospital Erlangen, Erlangen, Germany

Midkine expression in Uveal Cancer


More Details 


 2:30pm-2:45pm

 

Associate Professor Mine ErguvenIstanbul Aydin University, Istanbul, Turkey

Indomethicin decreased Midkine levels in the treatment of Glioblastoma


More Details


 2:45pm-3:00pm 

 

Dr Jeremy ClarkNorwich Medical School, University of East Anglia, UK

Analysis of Midkine protein and mRNA in Prostate Cancer Patient Urine Samples


More Details


 3:00pm-3:30pm          Afternoon tea and poster viewing

 3:30pm-5:00pm         SESSION 7 (Cont.): Midkine and cancer                           

 Session Moderator:     Joseph Haklani


 3:30pm-3:45pm

 

Professor Ayhan BilirZirve University, Gazientep, Turkey

Loss of Angiocidin expression increases Midkine in Endometrial cancer cells


More Details 


 3:45pm-4:00pm

 

Dr David DavilaComplutense Universidad, Madrid, Spain

Targeting the MDK/ALK axis as a potential therapeutic strategy in gliomas


More Details


 4:00pm-4:30pm

 

Professor Richard BarkerFounding Director, Centre for the Advancement of Sustainable Medical Innovation, Oxford UK

PLENARY 3: Bioscience - lost in translation? How precision medicine will close the innovation gap


More Details


 4:30pm-5:00pm
              
PANEL DISCUSSION: Therapeutic and clinical opportunities for midkine

Panelists: Dr Fintan Walton, Professor Richard Barker, Dr Vicki Campbell, Associate Professor Graham Robertson

 5:30pm Onward         Symposium Dinner